News
BRANFORD, Conn., Aug. 27, 2025 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision ...
AbbVie has written the next chapter in its epic quest to treat psychiatric disorders, agreeing to buy a psychedelic drug candidate from Gilgamesh Pharmaceuticals for up to $1.2 billion. Bloomberg ...
With two bags in tow, Indian serial entrepreneur Vartika Manasvi arrived in Toronto via Silicon Valley in 2018 on a visitor visa to sell her start-up idea. Within months, the founder of StackRaft, a ...
Alongside the Pixel 10 series, Pixel Watch 4, and the Pixel Buds 2a, Google dropped the first beta of Android 16's second quarterly platform release. Android 16 QPR1 should go stable in September, ...
Investing.com - BTIG upgraded Kratos Defense & Security (NASDAQ:KTOS) from Neutral to Buy and established a price target of $80.00. The upgrade follows Kratos’ downselection for the Marine Corps’ MUX ...
Superluminal to receive payments, equity investment, royalties Lilly, Novo pursuing GPCR-targeting drugs for obesity Superluminal's lead candidate not part of deal with Lilly Aug 14 (Reuters) - Eli ...
Louisiana awarded nearly $8.5M in federal ferry funding Four agencies to benefit: RTA, DOTD, Plaquemines Parish, St. Mary Parish Funds can be used for vessels, terminals, and operations Program aims ...
Diet weight loss company Noom announced it is launching a new program dubbed the Noom Microdose GLP-1Rx Program, which will provide members with personalized microdoses of GLP-1 medication. The ...
Hosted on MSN
How to Make Themed Character Cakes at Home
This video showcases a collection of creative character cake designs, including doll dress cakes, fruit-themed characters, cartoon faces, and playful layers inspired by pop culture. Using buttercream, ...
Pfizer's beleaguered obesity strategy has hit another setback as the pharma jettisoned its third and final GLP-1 agonist, citing poor data and tough competition. Pfizer's last remaining GLP-1 agonist, ...
A new $608 million grant program from the Federal Emergency Management Agency (FEMA) will give states money to build detention centers for people suspected of being in the United States unlawfully.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results